BLUESCOPE News & Analysis

Strong share price rallies have pulled this well-known blue-chip miner and an Australian software giant deeper into “overvalued” territory in recent...

Materials and health stocks are among the most overvalued ASX companies under Morningstar coverage. We identify 5 to avoid at current prices.

The value of these companies rose over the course of 2019, even if neither their share price gains, nor affordability shot the lights out.

The US business cycle has years until its peak and offers long-term growth prospects for Australian building materials player Boral, says Morningstar.

Pact's decision to appoint BlueScope's Sanjay Dayal as chief executive will help lead the specialist packaging company's turnaround and boost its...

BlueScope Steel may have posted a record first-half result, but it will be hard to sustain the momentum, warns Morningstar analyst Mathew Hodge.